Evidence for adjuvanticity of anthrax edema toxin.

Vaccine

Unité d'Immunobiologie, Département de biologie des agents transmissibles, Centre de Recherches du service de Santé des Armées (CRSSA), BP87, F-38702 La Tronche cedex; France.

Published: February 2006

Bacillus anthracis edema factor (EF) is an adenylate cyclase that increases intracellular cAMP concentrations. Since EF is present as a contaminant in the licensed protective antigen(PA)-based vaccines, we investigated its effect on anti-PA humoral immune response in BALB/c mice. We observed a significant increase of anti-PA IgG response in mice immunised with PA in association with EF as compared to PA alone. These results clearly show an adjuvant effect of EF, which is consistent with the data concerning the cellular effects of EF on antigen-presenting cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2005.08.065DOI Listing

Publication Analysis

Top Keywords

evidence adjuvanticity
4
adjuvanticity anthrax
4
anthrax edema
4
edema toxin
4
toxin bacillus
4
bacillus anthracis
4
anthracis edema
4
edema factor
4
factor adenylate
4
adenylate cyclase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!